Evidence map›Paper›PMID 34579760›Full record

ArticleJournal of experimental & clinical cancer research : CR2021

Dendrimer-modified gold nanorods as a platform for combinational gene therapy and photothermal therapy of tumors.

Lili Ye, Yaoming Chen, Jizong Mao, Xiaotian Lei, Qian Yang, Chunhui Cui

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Polymeric nanocarriers for therapeutic gene delivery.Asian journal of pharmaceutical sciences · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lili Ye *Department of Neuro-oncological Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
Yaoming Chen *Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
Jizong MaoDepartment of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
Xiaotian LeiDepartment of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
Qian YangDepartment of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
Chunhui CuiDepartment of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China. drcuich@163.com.
Zhujiang Hospital · CNSouthern Medical University · CN

Funding

national natural science foundation of china 8197032867science and technology planning project of guangzhou 201707010104
6 · The paper itself

Abstract

backgroundThe exploitation of novel nanomaterials combining diagnostic and therapeutic functionalities within one single nanoplatform is challenging for tumor theranostics.

methodsWe synthesized dendrimer-modified gold nanorods for combinational gene therapy and photothermal therapy (PTT) of colon cancer. Poly(amidoamine) dendrimers (PAMAM, G3) grafted gold nanorods were modified with GX1 peptide (a cyclic 7-mer peptide, CGNSNPKSC). The obtained Au NR@PAMAM-GX1 are proposed as a gene delivery vector to gene (FAM172A, regulates the proliferation and apoptosis of colon cancer cells) for the combination of photothermal therapy (PTT) and gene therapy of Colon cancer cells (HCT-8 cells). In addition, the CT imaging function of Au NR can provide imaging evidence for the diagnosis of colon cancer.

resultsThe results display that Au NR@PAMAM-GX1 can specifically deliver FAM172A to cancer cells with excellent transfection efficiency. The HCT-8 cells treated with the Au NR@PAMAM-GX1/FAM172A under laser irradiation have a viability of 20.45%, which is much lower than the survival rate of other single-mode PTT treatment or single-mode gene therapy. Furthermore, animal experiment results confirm that Au NR@PAMAM-GX1/FAM172A complexes can achieve tumor thermal imaging, targeted CT imaging, PTT and gene therapy after tail vein injection.

conclusionOur findings demonstrate that the synthesized Au NR@PAMAM-GX1 offer a facile platform to exert antitumor and improve the diagnostic level of tumor.

Indexed as

AnimalsApoptosisCell ProliferationColonic NeoplasmsCombined Modality TherapyDendrimersGenetic TherapyGene Transfer TechniquesGoldHumansMetal NanoparticlesMiceMice, NudeNanotubesPeptide FragmentsPhotothermal TherapyARB2A protein, humanDendrimersGoldPeptide FragmentsProteinsCancer treatmentDendrimersGene deliveryGold nanorodsPhotothermal therapy

Identifiers

PMID34579760
PMCPMC8477545
OpenAlexW3139433353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.